You are on page 1of 2

5/12/2016

Apreliminaryinvestigationofibogaine:casereportsandrecommendationsforfurtherstudy.PubMedNCBI

PubMed

Abstract
JSubstAbuseTreat.1994JulAug11(4):37985.

Apreliminaryinvestigationofibogaine:casereportsand
recommendationsforfurtherstudy.
SheppardSG.

Abstract
Anaturallyoccurringsubstance,ibogaine,wastakenbysevenindividuals
whowereaddictedtoopiates.Ibogaine,analkaloidwithpsychotropiceffects
atdosesof200300mgandabove,wastakeninsingledosesof7001800mg
bythesubjectsinthestudy.Attheendofthe2438hrpsychoactiveperiod
inducedbythedrugatthesedoses,noneofthesubjectsdisplayedsignificant
opiatewithdrawalsymptoms.Atthelowestdoseof700mg,onesubject
recontinuedhisdrugabuseafter2daysoftheremainingsixindividualswho
took1,000mgorabove,tworelapsedafteranumberofweeks,onereverted
tointermittentheroinuse,andthreeappeartohaveremaineddrugfree14
weeksormoreafterundergoingthisexperimentaltreatment.Ibogainemaybe
ofvalueinthepresentandcouldserveasamodelforthedevelopmentof
improvedagentsforthetreatmentofsubstanceabuseinthefuture.
PMID:7966509[PubMedindexedforMEDLINE]

PublicationTypes,MeSHTerms,Substances
LinkOutmoreresources

PubMedCommons

http://www.ncbi.nlm.nih.gov/pubmed/7966509

1/2

5/12/2016

Apreliminaryinvestigationofibogaine:casereportsandrecommendationsforfurtherstudy.PubMedNCBI

PubMedCommons

PubMedCommonshome

0comments
HowtojoinPubMedCommons

http://www.ncbi.nlm.nih.gov/pubmed/7966509

2/2

You might also like